In contrast, these renal pathological and functional injuries were markedly attenuated in tlr4f/f−lysM−cre mice (Fig. 1A–E), demonstrating a pathogenic role of myeloid TLR4 in anti-GBM GN. This evidence concerns the gene TLR4 and glioblastoma.